
|Articles|February 18, 2022
Daily Medication Pearl: Vortioxetine (Trintellix)
Author(s)Saro Arakelians, PharmD
Vortioxetine (Trintellix) treats major depressive disorder in adults.
Advertisement
Medication Pearl of the Day: Vortioxetine (Trintellix)
Indication: Trintellix is indicated for the treatment of major depressive disorder in adults.
Insight:
- Dosing: The recommended starting dose is 10 mg administered orally once daily without regard to meals
- Dosage forms: Tablets 5 mg, 10 mg, and 20 mg.
- Adverse events: Most common adverse reactions (incidence ≥5% and at least twice the rate of placebo) were nausea, constipation, and vomiting.
- Mechanism of action: The mechanism of the antidepressant effect of vortioxetine is not fully understood, but is thought to be related to its enhancement of serotonergic activity in the CNS through inhibition of the reuptake of serotonin.
- Manufacturer: Takeda Pharma
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ACIP Votes to End Universal Hepatitis B Vaccination Recommendation for Infants
2
MRD, ctDNA Testing May Help Diagnose Multiple Myeloma Precursor Conditions
3
Longevity Medicine: Just Another Reincarnation of Diet and Exercise or Something Altogether Different?
4
Low-Dose Cannabinoids Show Potential to Restore Serotonin Levels and Reduce Inflammation in HIV, Study Finds
5


















































































































































































































